NDC 68788-7781 – Tizanidine

Tizanidine Hydrochloride 4 mg/1 · Tablet · Oral

Human Prescription Drug 1 recall

Product NDC68788-7781

Product details

Brand name
Tizanidine
Generic name
Tizanidine
Labeler
Preferred Pharmaceuticals, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA076286
Marketed since
September 1, 2020
Listing expires
December 31, 2026
Pharmacologic class
Central alpha-2 Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Tizanidine →

Package NDC codes (6)

Package NDCDescriptionSince
68788-7781-1100 TABLET in 1 BOTTLE (68788-7781-1)Sep 1, 2020
68788-7781-220 TABLET in 1 BOTTLE (68788-7781-2)Sep 1, 2020
68788-7781-330 TABLET in 1 BOTTLE (68788-7781-3)Sep 1, 2020
68788-7781-660 TABLET in 1 BOTTLE (68788-7781-6)Sep 1, 2020
68788-7781-8120 TABLET in 1 BOTTLE (68788-7781-8)Sep 1, 2020
68788-7781-990 TABLET in 1 BOTTLE (68788-7781-9)Sep 1, 2020

Recalls mentioning this NDC

Other Tizanidine products